Shanghai, June 26, 2025 — The 23rd CPHI China 2025, one of the world’s premier pharmaceutical trade shows, successfully concluded at the Shanghai New International Expo Centre. The event reached an unprecedented scale, covering over 230,000 square meters and hosting more than 3,500 leading exhibitors from around the globe, including nearly 300 top-tier international brands.Longzen made a strong impression at the event, engaging extensively with both new and existing partners. The team held in-depth discussions around its thioctic acid (also known as alpha lipoic acid), Gadobutrol, Teneligliptin and other APIs and key intermediates, showcasing the company’s innovation and commitment to quality.Longzen’s presence at CPHI China 2025 highlights its growing influence in the global pharmaceutical market and its dedication to building strong, collaborative relationships across the industry.
